Comparison alteration of blood glucose level in continue against discontinue usage metformin tablet in diabetic type II patients before surgery

Comparison alteration of blood glucose level in continue against discontinue usage metformin tablet in diabetic type II patients untill morning of coronary artery graft surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014092210348N2

Enrollment

Registered

2014-12-13

Start date

2014-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabet. Non-insulin-dependent diabetes mellitus

Interventions

intervention: Discontinue metformin tablet one day before surgery control: Continue metformin tablet until morning the day of surgery.

Treatment - Drugs

intervention: Discontinue metformin tablet one day before surgery control: Continue metformin tablet until morning the day of surgery

Eligibility

Sex/Gender

All

Age

25 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: All diabetic type II patients between 25 to 100 years old who candidate for elective coronary bypass graft surgery. Exclusion criteria: Emergency coronary bypass graft surgery; diabetic type I; heart faiure (EF 20mg/dl or Cr > 1.5 mg/dl); Off- pump coronary bypass grafsurgery and usage metformin more than 1000mg/day.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Blood glucose level. Timepoint: Before and during and after surgery. Method of measurement: mg/dl.	—

Secondary

Measure	Time frame
Blood cratenin level. Timepoint: Before and during and after surgery. Method of measurement: mg/dl.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoud Tarbiat

Hamedan University Of Medical Sciences

masoudtarbiat@gmail.com+98 81 3423 2052

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026